Pharmacokinetic comparison of the 6mg/24hr and 12mg/24hr Emsam (selegiline transdermal system) in healthy elderly and non-elderly volunteers
Latest Information Update: 18 Jan 2010
At a glance
- Drugs Selegiline (Primary)
- Indications Alzheimer's disease; Depressive disorders; Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Somerset Pharmaceuticals
- 02 Oct 2007 New trial record.